109 related articles for article (PubMed ID: 7410841)
21. Deficiency in the ability of serum from pigs on an atherogenic diet to stimulate the migration of 3T3 cells in culture.
Bürk RR; Clopath B; Muller K
Artery; 1979; 5(6):205-19. PubMed ID: 232977
[TBL] [Abstract][Full Text] [Related]
22. In vitro effects of human lipoproteins on the immune system in healthy donors: inhibition of plaque forming cell generation and decreased frequency of NK cells.
Antonaci S; Jirillo E; Ventura MT; Capurso A; Garofalo AR; Bonomo L
Clin Exp Immunol; 1984 Jun; 56(3):677-82. PubMed ID: 6378455
[TBL] [Abstract][Full Text] [Related]
23. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
24. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Ia antigens in mouse serum.
Callahan GN; Ferrone S; Poulik MD; Reisfeld RA; Klein J
J Immunol; 1976 Oct; 117(4):1351-5. PubMed ID: 185298
[TBL] [Abstract][Full Text] [Related]
26. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
[TBL] [Abstract][Full Text] [Related]
27. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
28. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
29. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
30. Carboxyphenyl chloroanthranilic acid (CCA) in the modulation of immune response in mice.
Nakazawa T; Abe C; Shiokawa Y; Kamijo K
Int J Tissue React; 1984; 6(1):23-34. PubMed ID: 6715117
[TBL] [Abstract][Full Text] [Related]
31. Serum-free culture of PC13 murine embryonal carcinoma cells.
Heath JK; Deller MJ
J Cell Physiol; 1983 Jun; 115(3):225-30. PubMed ID: 6853605
[TBL] [Abstract][Full Text] [Related]
32. Effect of human plasmalipoproteins on erythropoietic progenitor cells in serum-free cultures.
Konwalinka G; Breier C; Peschel C; Geissler D; Lisch HJ; Braunsteiner H
Blut; 1986 Mar; 52(3):191-5. PubMed ID: 3633746
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the activities in inhibition of haemagglutination by different togaviruses for human serum lipoproteins and their constituents.
Shortridge KF; Ho WK
J Gen Virol; 1976 Dec; 33(3):523-7. PubMed ID: 187726
[TBL] [Abstract][Full Text] [Related]
34. Induction of macrophage growth by the lipid moiety of lipoprotein and its augmentation by denaturation of the lipoproteins.
Yui S; Mizuno D; Yamazaki M
J Leukoc Biol; 1985 Dec; 38(6):697-707. PubMed ID: 3864909
[TBL] [Abstract][Full Text] [Related]
35. Reversible inhibition by human serum lipoproteins of cell proliferation.
Ito F; Takii Y; Suzuki J; Masamune Y
J Cell Physiol; 1982 Oct; 113(1):1-7. PubMed ID: 6215416
[TBL] [Abstract][Full Text] [Related]
36. Modulation of human T lymphocyte rosette formation by serum factors.
Skibiński G; Wieczorek Z; Zwoliński J
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):351-6. PubMed ID: 35127
[TBL] [Abstract][Full Text] [Related]
37. Characterization of lymphocyte E rosette inhibitory factor in sera from tuberculous patients.
Wieczorek Z; Skibiński G; Zwoliński J
Arch Immunol Ther Exp (Warsz); 1977; 25(1):63-8. PubMed ID: 327969
[TBL] [Abstract][Full Text] [Related]
38. Role of high-, low- and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo.
Barel A; Jori G; Perin A; Romandini P; Pagnan A; Biffanti S
Cancer Lett; 1986 Aug; 32(2):145-50. PubMed ID: 3756840
[TBL] [Abstract][Full Text] [Related]
39. High-density lipoprotein prevents SAA-induced production of TNF-α in THP-1 monocytic cells and peripheral blood mononuclear cells.
Franco AG; Sandri S; Campa A
Mem Inst Oswaldo Cruz; 2011 Dec; 106(8):986-92. PubMed ID: 22241121
[TBL] [Abstract][Full Text] [Related]
40. [Changes in the rosette-forming capacity of peripheral blood lymphocytes in patients with ischemic heart disease after administration of atherogenic lipoproteins].
Vasil'chenko EM; Beĭko VA; Tymchishin PN; Karpov RS
Kardiologiia; 1989 Feb; 29(2):53-6. PubMed ID: 2786106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
